YS Projected Dividend Yield
LakeShore Biopharma Co., Ltd ( NASDAQ : YS )YS Biopharma Co. is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. Co.'s vaccine product, YSJA rabies vaccine is an aluminum-free lyophilized rabies vaccine launched in China. YSJA™ rabies vaccine improves the suitability of human rabies vaccine to rabies in China and causes less pain, injection site discomfort and fever to patients. In addition to the commercialized YSJA™ rabies vaccine, Co. also has a pipeline of vaccine candidates PIKA immunomodulating technology platform. 20 YEAR PERFORMANCE RESULTS |
YS Dividend History Detail YS Dividend News YS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |